BioWorld. Link to homepage.
BioWorld
BioWorld MedTech
BioWorld Asia
BioWorld Science
Data Snapshots
BioWorld
BioWorld MedTech
Infographics: Dynamic digital data analysis
Special reports
Aging
Biosimilars
Artificial intelligence
Coronavirus
Infographics: Dynamic digital data analysis
Israel
IVDs on the rise
Radiopharmaceuticals
Rise of obesity
Top Biopharma Trends of 2023
Top Med-tech Trends of 2023
Top Preclinical Trends of 2023
Premium reports
BioWorld Financings Reports
Disease Incidence & Prevalence Summaries
BioWorld. Link to homepage.
sign in
Sign Out
My Account
Subscribe
BioWorld - Thursday, March 28, 2024
Home
»
Newsletters
» BioWorld
BioWorld
Sep. 22, 2006
View Archived Issues
Merck KGaA Buying Serono, Giving CHF16.6B Valuation
Merck KGaA agreed to acquire a controlling stake in Serono SA by purchasing the Bertarelli family's shares in the company, which represent 64.5 percent of its equity and 75.5 percent of its voting rights. (BioWorld Today)
Read More
Phase II Alzheimer's Results Boost Shares Of Medivation
Read More
Alzheimer's, Like Prion Disease, 'Seeded' By Misshapen Proteins
Read More
Alexion Seeks FDA Approval For Soliris In PNH Indication
Read More
Axcan Drops ITAX In Functional Dyspepsia After Phase III Failure
Read More
Biogen Joins With Alnylam On RNAi Therapies For PML
Read More
Clinic Roundup
Read More
Appointments And Advancements
Read More
Other News To Note
Read More